How do you take magnesium glycinate?
| Product | Form | Magnesium per serving | Label directions |
|---|---|---|---|
| Doctor's Best | Tablet | 200 mg elemental magnesium per 2 tablets, from 2,000 mg magnesium glycinate/lysinate chelate1 | Suggested adult use: 2 tablets twice daily, with or without food1 |
| Designs for Health | Capsule | 300 mg magnesium per 2 capsules2 | Two capsules per day, or as directed by a health care practitioner2 |
| Thorne | Powder | 200 mg magnesium per 3.11 g scoop3 | 1 scoop in at least 8 ounces of water daily, or as recommended by a health-care practitioner3 |
The Doctor's Best label's suggested adult use is 2 tablets twice daily, the Designs for Health label gives two capsules per day and the Thorne powder label gives 1 scoop in at least 8 ounces of water daily; in the Schuster trial of 155 adults with self-reported poor sleep, the magnesium bisglycinate arm took 250 mg of elemental magnesium daily against placebo for 28 days.1234
What the labels give
The table is set at the top of the page
A second Thorne powder label gives a 3.95 g scoop, mixed with at least 8 ounces of water one to two times daily.5 None of the saved labels or trials gives one elemental magnesium share for magnesium glycinate. The share differs by product: 200 mg elemental from 2,000 mg of chelate on the Doctor's Best label,1 and 125 mg in 893 mg of magnesium bisglycinate in the sleep trial's capsules.4
Mixing the powder
Of the saved labels, only the two Thorne powder labels give mixing directions: one with a daily scoop in at least 8 ounces of water3 and the other with one to two times daily,5 and neither gives a water temperature.
What human trials gave
| Trial | Dose and schedule | People | Length |
|---|---|---|---|
| Schuster, sleep | 250 mg elemental magnesium daily as magnesium bisglycinate, two capsules 30 to 60 minutes before bedtime, against placebo capsules4 | 155 adults aged 18 to 65 with self-reported poor sleep | 28 days |
| Mayo Clinic registry entry NCT03564665, hot flashes (no results posted) | 400 mg magnesium glycinate twice daily (BID), against placebo twice daily6 | 40 women aged 25 to 85 with a history of breast cancer, DCIS or LCIS | 8 weeks |
| Maddirevula 2026, asthma or COPD | 440 mg magnesium glycinate daily by mouth, against placebo, alongside standard therapy7 | 224 adults with asthma or COPD and confirmed hypomagnesemia | 12 months |
Two single-dose absorption crossovers compared several magnesium forms, bisglycinate among them: the Pajuelo MAGSHAPE trial gave 375 mg of elemental magnesium from each of four products to 40 healthy volunteers aged 20 to 55,8 and the Natural Calm registry entry NCT03353636 gave 150 mg of elemental magnesium to 12 healthy post-menopausal women aged 35 to 65 in a five-period crossover.9 Searches of DailyMed, ClinicalTrials.gov and PubMed found no label or trial giving a cycle of weeks on and off or a stepped dose for magnesium glycinate. None of the saved magnesium glycinate labels gives a time of day for sleep; the only saved magnesium bisglycinate sleep trial that does is the Schuster trial, at 30 to 60 minutes before bedtime.4
Upper limits and cautions
The NHS says that having 400mg or less a day of magnesium from supplements is unlikely to cause harm.10 It also says that high doses of more than 400mg for a short time can cause diarrhoea.10 It adds that evidence on long-term high doses is limited.10 EFSA's overview lists 250 mg a day as the tolerable upper intake level for magnesium, applied to readily dissociable magnesium salts and compounds like magnesium oxide in food supplements, water or added to foods, not to magnesium naturally present in foods.11 Whether that wording covers magnesium glycinate is not stated in the saved text.
In the Schuster sleep trial, 93% of participants in both arms reported no adverse events, none were serious, and two placebo participants withdrew for gastrointestinal issues.4 In the Pajuelo MAGSHAPE crossover, after a single 375 mg dose of elemental magnesium from each product, more volunteers reported gastric heaviness with magnesium bisglycinate and with magnesium oxide than with the microencapsulated oxide.8 Kidney disease and drug interaction cautions were not found in the saved labels or pages.
Combining with other magnesium forms
Searches of PubMed and DailyMed found no trial or label giving magnesium glycinate and magnesium L-threonate together as a stated regimen. The 12-week Cheung 2022 trial randomised 95 participants with overweight or obesity to three arms: 360 mg magnesium glycinate + 1000 IU vitamin D 3 × daily, vitamin D only, or placebo.12
Storage
Both Thorne powder labels say to use only if the bottle is sealed and to store it tightly sealed in a cool, dry place.35 The Designs for Health capsule label says to store in a cool, dry place.2 The Doctor's Best tablet label has no storage line, and no label gives a time or temperature for powder once mixed into water.
Frequently asked questions
Is there an approved label for magnesium glycinate?
A DailyMed search found no regulator-approved single-ingredient magnesium glycinate label, only multivitamin or prenatal products listing glycinate chelates, and ClinicalTrials.gov lists its studies as dietary-supplement or other interventions, none a drug approval.
References
- NIH DSLD label record (Doctor's Best). Fully Reacted! Not Buffered!. api.ods.od.nih.gov
- NIH DSLD label record. Recommended Use: As a dietary. api.ods.od.nih.gov
- NIH DSLD label record (Thorne). SUPPLEMENT FACTS † This product uses Tate and Lyle’s Purefruit. api.ods.od.nih.gov
- Journal article (PMC). Magnesium Bisglycinate Supplementation in Healthy Adults Reporting Poor Sleep: A Randomized, Placebo-Controlled Trial. 2025. pmc.ncbi.nlm.nih.gov
- NIH DSLD label record. SUPPLEMENT FACTS. api.ods.od.nih.gov
- ClinicalTrials.gov. NCT03564665: Investigating Magnesium Glycinate in Structure/Function Role of Hot Flashes. 2021. clinicaltrials.gov
- PubMed. Efficacy and safety of magnesium glycinate as add on therapy in hypomagnesemic asthma and chronic obstructive pulmonary disease patients: A randomised controlled study assessing inflammatory biomarkers. 2026. pubmed.ncbi.nlm.nih.gov
- Journal article (PMC). Comparative Clinical Study on Magnesium Absorption and Side Effects After Oral Intake of Microencapsulated Magnesium (MAGSHAPE TM Microcapsules) Versus Other Magnesium Sources. 2024. pmc.ncbi.nlm.nih.gov
- ClinicalTrials.gov. NCT03353636: Bioavailability of Magnesium Supplements. 2017. clinicaltrials.gov
- NHS. Vitamins and minerals - Others. nhs.uk
- EFSA. Title of the Technical report. efsa.europa.eu
- PubMed. The effect of combined magnesium and vitamin D supplementation on vitamin D status, systemic inflammation, and blood pressure: A randomized double-blinded controlled trial. 2022. pubmed.ncbi.nlm.nih.gov